Ronald W. Penczek - Mar 1, 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
CAO & Controller
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Mar 1, 2024
Transactions value $
-$191,159
Form type
4
Date filed
3/5/2024, 04:32 PM
Previous filing
Dec 1, 2023
Next filing
Mar 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -$191K -383 -21.38% $499.11 1.41K Mar 1, 2024 Direct F1
transaction ELV Common Stock Award $0 +226 +16.05% $0.00 1.63K Mar 1, 2024 Direct F2
transaction ELV Common Stock Award $0 +1.05K +64.01% $0.00 2.68K Mar 1, 2024 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +867 $0.00 867 Mar 1, 2024 Common Stock 867 $499.11 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows: 75 shares each on 3/1/2025 and 3/1/2026 and 76 shares on 3/1/2027.
F3 Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
F4 Balance includes 4.20 shares acquired on December 21, 2023 through a dividend reinvestment plan.
F5 The option represents a right to purchase a total of 867 shares, and is exercisable in three annual installments of 289 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.